Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database (scientific article published on 16 February 2007)

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections

Q28189095

Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada.

Q33756649

Nosocomial respiratory syncytial virus infections: the "Cold War" has not ended

Q34033632

International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics

Q34382371

Practical issues concerning imaging of pulmonary infection in children

Q34422310

Community-acquired pneumonia in children

Q34520687

Hospital-acquired viral pathogens in the neonatal intensive care unit.

Q35009376

Systematic review of the biology and medical management of respiratory syncytial virus infection

Q35095322

Selected populations at increased risk from respiratory syncytial virus infection

Q35097198

Respiratory syncytial virus infections in the pediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes

Q35148354

Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease

Q35277282

Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease

Q35582853

Respiratory syncytial virus: the virus, the disease and the immune response

Q35674155

Practice variation among pediatric emergency departments in the treatment of bronchiolitis

Q35738162

Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants.

Q36153760

Prevention and treatment of respiratory syncytial virus infection in infants: an update

Q36445553

Reliable detection of respiratory syncytial virus infection in children for adequate hospital infection control management

Q39466025

Performance characteristics of VIDAS and directigen respiratory syncytial virus (RSV) antigen detection assays and culture for the identification of RSV in respiratory specimens

Q39665241

Evaluation of the Abbott TESTPACK RSV enzyme immunoassay for detection of respiratory syncytial virus in nasopharyngeal swab specimens

Q40199585

Identification of cell lines permissive for human coronavirus NL63.

Q40233918

Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization

Q40419286

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection

Q43426670

Nosocomial respiratory syncytial virus infection: impact of prospective surveillance and targeted infection control

Q43563763

Nosocomial respiratory syncytial virus: a threat in the modern neonatal intensive care unit

Q43745406

Palivizumab prophylaxis of respiratory syncytial virus disease in 2000–2001: Results from the palivizumab outcomes registry

Q43821315

Bronchiolitis: assessment and evidence-based management.

Q44847695

Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course

Q45403579

Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections

Q45417824

Impact of palivizumab on admission to the ICU for respiratory syncytial virus bronchiolitis: a national survey

Q45423184

Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit.

Q45593191

Anticipated costs of hospitalization for respiratory syncytial virus infection in young children at risk

Q45627586

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

Q45710733

Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use.

Q45722015

Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany

Q45728687

Respiratory syncytial virus (RSV) outbreak in the NICU: description of eight cases

Q45732464

Antibiotic use in pediatric intensive care patients with lower respiratory tract infection due to respiratory syncytial virus

Q45736033

The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit

Q45736604

International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group.

Q45756843

Clinical severity of respiratory syncytial virus group A and B infection in Sydney, Australia.

Q45776881

Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions

Q45830488

Respiratory syncytial virus infection in children with bronchopulmonary dysplasia

Q45831967

Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany

Q47777594

Viral respiratory infections in children with technology dependence and neuromuscular disorders

Q47885934

Viral etiology of acute respiratory tract infections in children presenting to hospital: role of polymerase chain reaction and demonstration of multiple infections

Q47895254

Palivizumab use in very premature infants in the neonatal intensive care unit

Q47902160

Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study).

Q47925908

RSV outbreak in a paediatric intensive care unit

Q47959637

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection.

Q50588783

Economic evaluation of possible prevention of RSV-related hospitalizations in premature infants in Germany.

Q51681461

Burden of respiratory syncytial viral infections on paediatric hospitals: a two-year prospective epidemiological study.

Q51721437

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

Q77300551

P433

issue

P921

main subject

hospitalization

Q3140971

P304

page(s)

1273-1283

P577

publication date

2007-02-16

P1433

published in

European Journal of Pediatrics

Q15755736

P1476

title

Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database

P478

volume

166

Reverse relations

cites work (P2860)

Q37268852	Apnea in children hospitalized with bronchiolitis
Q45324366	Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants
Q28067464	Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease
Q40906103	Differences Between Radiologically Confirmed Pneumonia With and Without Pleural Fluid in Hospitalized Children Younger Than 5 Years in Southern Israel
Q116164903	ELAC2, an Enzyme for tRNA Maturation, Plays a Role in the Cleavage of a Mature tRNA to Produce a tRNA-Derived RNA Fragment During Respiratory Syncytial Virus Infection
Q37776266	Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children
Q37130695	Maternal smoking during pregnancy, prematurity and recurrent wheezing in early childhood
Q33415268	Neurological complications of respiratory syncytial virus infection: case series and review of literature
Q43590229	Prospective population-based study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001-2005).
Q31127401	Prospective study of Human Bocavirus (HBoV) infection in a pediatric university hospital in Germany 2005/2006.
Q37452172	Protective efficacy and immunogenicity of an adenoviral vector vaccine encoding the codon-optimized F protein of respiratory syncytial virus.
Q36295566	Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses.
Q45388435	Respiratory syncytial virus infection in children admitted to hospital but ventilated mechanically for other reasons
Q40298671	Respiratory syncytial virus infection in children with neuromuscular impairment
Q54292169	Respiratory viruses in neonates hospitalized with acute lower respiratory tract infections.
Q36194002	Risk Factors of Early Otitis Media in the Danish National Birth Cohort
Q40412523	Risk factors for severe respiratory syncytial virus lower respiratory tract infection
Q38604949	Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention
Q59631088	The year in review

P6179	Dimensions Publication ID	1021367225
P356	DOI	10.1007/S00431-007-0426-Y
P698	PubMed publication ID	17943313